A multinational consensus on dysphagia in Parkinson's disease: screening, diagnosis and prognostic value

G Cosentino, M Avenali, A Schindler, N Pizzorni… - Journal of …, 2022 - Springer
Background Parkinson's disease (PD) is a neurodegenerative disorder characterized by a
combination of motor and non-motor dysfunction. Dysphagia is a common symptom in PD …

Gastrointestinal dysfunctions in Parkinson's disease: symptoms and treatments

AA Poirier, B Aubé, M Côté, N Morin… - Parkinson's …, 2016 - Wiley Online Library
A diagnosis of Parkinson's disease is classically established after the manifestation of motor
symptoms such as rigidity, bradykinesia, and tremor. However, a growing body of evidence …

Risk and mortality of aspiration pneumonia in Parkinson's disease: a nationwide database study

JH Won, SJ Byun, BM Oh, SJ Park, HG Seo - Scientific reports, 2021 - nature.com
This retrospective cohort study investigated the risk and mortality rate due to aspiration
pneumonia in patients with Parkinson's disease (PD) using a nationwide database. We …

From mitochondrial function to neuroprotection—an emerging role for methylene blue

D Tucker, Y Lu, Q Zhang - Molecular neurobiology, 2018 - Springer
Methylene blue (MB) is a well-established drug with a long history of use, owing to its
diverse range of use and its minimal side effect profile. MB has been used classically for the …

Factors associated with hospitalisation among people with Parkinson's disease–a systematic review and meta-analysis

O Okunoye, G Kojima, L Marston, K Walters… - Parkinsonism & Related …, 2020 - Elsevier
Introduction Parkinson's disease (PD) is associated with an increased risk of admission to
hospital; however data on the main reasons for admission are lacking. Our objective was to …

Gastrointestinal dysfunction in Parkinson's disease: current and potential therapeutics

MN Han, DI Finkelstein, RM McQuade… - Journal of Personalized …, 2022 - mdpi.com
Abnormalities in the gastrointestinal (GI) tract of Parkinson's disease (PD) sufferers were first
reported over 200 years ago; however, the extent and role of GI dysfunction in PD disease …

ALS-related FUS mutations alter axon growth in motoneurons and affect HuD/ELAVL4 and FMRP activity

MG Garone, N Birsa, M Rosito, F Salaris… - Communications …, 2021 - nature.com
Mutations in the RNA-binding protein (RBP) FUS have been genetically associated with the
motoneuron disease amyotrophic lateral sclerosis (ALS). Using both human induced …

[HTML][HTML] Clinical implications of gastric complications on levodopa treatment in Parkinson's disease

RF Pfeiffer, SH Isaacson, R Pahwa - Parkinsonism & Related Disorders, 2020 - Elsevier
Disorders of the gastrointestinal (GI) tract are common and distressing nonmotor symptoms
of Parkinson's disease (PD) that can adversely affect levodopa absorption and lead to OFF …

Death certificate data and causes of death in patients with parkinsonism

M Moscovich, G Boschetti, A Moro, HAG Teive… - Parkinsonism & Related …, 2017 - Elsevier
Introduction Assessment of variables related to mortality in Parkinson disease (PD) and
other parkinsonian syndromes relies, among other sources, on accurate death certificate …

Mortality and morbidity after spinal surgery in patients with Parkinson's disease: a retrospective matched-pair cohort study

T Oichi, H Chikuda, J Ohya, R Ohtomo, K Morita… - The Spine Journal, 2017 - Elsevier
Abstract Background Context There is a lack of information about postoperative outcomes
and related risk factors associated with spinal surgery in patients with Parkinson's disease …